UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical and positron emission tomography findings of chorea associated with primary antiphospholipid antibody syndrome

Movement disorders, 2007-09, Vol.22 (12), p.1813-1815

2007

Volltextzugriff (PDF)

Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura

Nature (London), 2001-10, Vol.413 (6855), p.488-494

2001

Volltextzugriff (PDF)

Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2022-01, Vol.327 (2), p.129

2022

Volltextzugriff (PDF)

Outcomes in children with deep vein thrombosis managed with percutaneous endovascular thrombolysis

Pediatric radiology, 2015-04, Vol.45 (5), p.719-726

2015

Volltextzugriff (PDF)

Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma/albumin-free method: pharmacokinetics, efficacy, and safety in previously treated patients with haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2004-09, Vol.10 (5), p.428-437

2004

Volltextzugriff (PDF)

BAY 81-8973 safety and efficacy for prophylaxis and treatment of bleeds in previously treated children with severe haemophilia A: results of the LEOPOLD Kids Trial

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-05, Vol.22 (3), p.354-360

2016

Volltextzugriff (PDF)

Legg-Calve-Perthes disease and thrombophilia

Journal of bone and joint surgery. American volume, 2004-12, Vol.86 (12), p.2642-2647

2004

Volltextzugriff (PDF)

Data Coming out of the Human Inhibitor PUP Study (HIPS) Reveal 4 Subgroups of Patients with Distinct Antibody Signatures

Blood, 2018-11, Vol.132 (Supplement 1), p.3774-3774

2018

Volltextzugriff (PDF)

Evidence for the transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates in the era of nucleic acid test screening

Transfusion (Philadelphia, Pa.), 2013-06, Vol.53 (6), p.1217-1225

2013

Volltextzugriff (PDF)

Perioperative Efficacy of an Extended Half-Life, Pegylated, Full-Length, Recombinant Factor VIII (BAX 855) in Individual Procedures

Blood, 2015-12, Vol.126 (23), p.2299-2299

2015

Volltextzugriff (PDF)

F8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-01, Vol.19 (1), p.113-118

2013

Volltextzugriff (PDF)

Appearance of High-Affinity Antibodies Precedes Clinical Diagnosis of FVIII Inhibitors - Preliminary Analysis from the Hemophilia Inhibitor PUP Study (HIPS)

Blood, 2016-12, Vol.128 (22), p.328-328

2016

Volltextzugriff (PDF)

Low-dose tissue plasminogen activator thrombolysis in children

Journal of pediatric hematology/oncology, 2003-05, Vol.25 (5), p.379-386

2003

Volltextzugriff (PDF)

Clinical and molecular variability in congenital dyserythropoietic anaemia type I

British journal of haematology, 2005-08, Vol.130 (4), p.628-634

2005

Volltextzugriff (PDF)

Evidence for the continued transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates

Transfusion (Philadelphia, Pa.), 2013-05, Vol.53 (5), p.1143-1144

2013

Volltextzugriff (PDF)

Evidence for the continued transmission of parvovirus B 19 in patients with bleeding disorders treated with plasma‐derived factor concentrates

Transfusion (Philadelphia, Pa.), 2013-05, Vol.53 (5), p.1143-1144

2013

Volltextzugriff (PDF)

Favorable histology, MYCN-amplified 4S neonatal neuroblastoma

Pediatric Blood & Cancer, 2007-04, Vol.48 (4), p.479-482

2007

Volltextzugriff (PDF)

Continued Transmission of Parvovirus B19 in Plasma-Derived Factor Concentrates After the Implementation of B19 Nucleic Acid Plasma Minipool Screening

Blood, 2011-11, Vol.118 (21), p.3378-3378

2011

Volltextzugriff (PDF)

Legg-Perthes disease in three siblings, two heterozygous and one homozygous for the factor V Leiden mutation

The Journal of pediatrics, 1998-05, Vol.132 (5), p.885-888

1998

Volltextzugriff (PDF)

Therapeutic choices for patients with hemophilia and high‐titer inhibitors

American journal of hematology, 2001-08, Vol.67 (4), p.240-246

2001

Volltextzugriff (PDF)

Germline origins in the human F9 gene : frequent G:C→A:T mosaicism and increased mutations with advanced maternal age

Human genetics, 1999-12, Vol.105 (6), p.629-640

1999

Volltextzugriff (PDF)

Therapeutic choices for patients with hemophilia and high‐titer inhibitors

American journal of hematology, 2002-02, Vol.69 (2), p.155-156

2002

Volltextzugriff (PDF)

Protein C Deficiency Resulting From Possible Double Heterozygosity and Its Response to Danazol

Blood, 1988-02, Vol.71 (2), p.370-374

1988

Volltextzugriff (PDF)

Fatal myocardial necrosis associated with prothrombin-complex-concentrate therapy in hemophilia A

The New England journal of medicine, 1983-07, Vol.309 (4), p.242-243

1983

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical and positron emission tomography findings of chorea associated with primary antiphospholipid antibody syndrome

Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura

Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial

Outcomes in children with deep vein thrombosis managed with percutaneous endovascular thrombolysis

Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma/albumin-free method: pharmacokinetics, efficacy, and safety in previously treated patients with haemophilia A

BAY 81-8973 safety and efficacy for prophylaxis and treatment of bleeds in previously treated children with severe haemophilia A: results of the LEOPOLD Kids Trial

Legg-Calve-Perthes disease and thrombophilia

Data Coming out of the Human Inhibitor PUP Study (HIPS) Reveal 4 Subgroups of Patients with Distinct Antibody Signatures

Evidence for the transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates in the era of nucleic acid test screening

Perioperative Efficacy of an Extended Half-Life, Pegylated, Full-Length, Recombinant Factor VIII (BAX 855) in Individual Procedures

Longitudinal Antibody Signatures Following FVIII Replacement Therapy in Previously Untreated Patients with Severe Hemophilia Α- New Insights from the Hemophilia Inhibitor PUP Study (HIPS)

F8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort

Appearance of High-Affinity Antibodies Precedes Clinical Diagnosis of FVIII Inhibitors - Preliminary Analysis from the Hemophilia Inhibitor PUP Study (HIPS)

Low-dose tissue plasminogen activator thrombolysis in children

Clinical and molecular variability in congenital dyserythropoietic anaemia type I

Evidence for the continued transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates

Evidence for the continued transmission of parvovirus B 19 in patients with bleeding disorders treated with plasma‐derived factor concentrates

Favorable histology, MYCN-amplified 4S neonatal neuroblastoma

Continued Transmission of Parvovirus B19 in Plasma-Derived Factor Concentrates After the Implementation of B19 Nucleic Acid Plasma Minipool Screening

Legg-Perthes disease in three siblings, two heterozygous and one homozygous for the factor V Leiden mutation

Therapeutic choices for patients with hemophilia and high‐titer inhibitors

Germline origins in the human F9 gene : frequent G:C→A:T mosaicism and increased mutations with advanced maternal age

Therapeutic choices for patients with hemophilia and high‐titer inhibitors

Protein C Deficiency Resulting From Possible Double Heterozygosity and Its Response to Danazol

Fatal myocardial necrosis associated with prothrombin-complex-concentrate therapy in hemophilia A

Suchergebnisse filtern